Thymosin Alpha-1 10mg

$167.00

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide naturally produced in the thymus gland and derived from the larger prothymosin alpha protein. Known for its powerful immunomodulatory properties, Tα1 plays a vital role in enhancing, restoring, and regulating immune function, particularly by supporting T cell differentiation, development, and maturation. Synthetic versions, such as thymalfasin, have been approved in over 35 countries for clinical use in treating viral infections, immunodeficiency disorders, and as an adjunct therapy in certain cancers. Tα1 continues to be a critical therapeutic option in promoting immune resilience and recovery.

Description

Referenced Citations

  1. Baralt, D., et al. (2020). “Thymosin alpha 1: A comprehensive review of the literature.” World Journal of Clinical Cases, 8(23), 5821-5832. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747025/
  2. Tao, N., et al. (2023). “Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.” International Journal of Molecular Sciences, 24(8), 7296. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144173/
  3. Li, J., et al. (2013). “Thymosin alpha 1: Biological activities, applications and genetic engineering production.” Peptides, 46, 1-8. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115394/
  4. Costantini, C., et al. (2019). “A Reappraisal of Thymosin Alpha1 in Cancer Therapy.” Frontiers in Oncology, 9, 873. [Online].
    Available: https://www.frontiersin.org/articles/10.3389/fonc.2019.00873/full
  5. ChemicalBook. (2024). “Thymosin α1 | 62304-98-7.” [Online].
    Available: https://www.chemicalbook.com/ChemicalProductProperty_EN_CB7678989.htm
  6. Costanzo, M., et al. (2021). “Thymosin α1 for prevention of severe COVID-19 in cancer patients.” Pharmacological Research, 163, 105302. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874885/